Oral Bronchodilator Combination Product Final Rule Issued By FDA
This article was originally published in The Tan Sheet
Executive Summary
Oral bronchodilator active ingredients cannot be combined with analgesic, antihistamine or stimulant active ingredients in OTC cough/cold products without an approved NDA, FDA determines in a final rule published in the Sept. 27 Federal Register.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning